BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23644387)

  • 1. Methods for diagnosis of bile acid malabsorption in clinical practice.
    Vijayvargiya P; Camilleri M; Shin A; Saenger A
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1232-9. PubMed ID: 23644387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Fecal Primary Bile Acids Detects Increased Stool Weight and Colonic Transit in Patients With Chronic Functional Diarrhea.
    Vijayvargiya P; Camilleri M; Chedid V; Carlson P; Busciglio I; Burton D; Donato LJ
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):922-929.e2. PubMed ID: 29902647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods for diagnosing bile acid malabsorption: a systematic review.
    Lyutakov I; Ursini F; Penchev P; Caio G; Carroccio A; Volta U; De Giorgio R
    BMC Gastroenterol; 2019 Nov; 19(1):185. PubMed ID: 31726982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter Prospective Study to Investigate the Diagnostic Accuracy of the SeHCAT Test in Measuring Bile Acid Malabsorption: Research Protocol.
    Reid F; Peacock J; Coker B; McMillan V; Lewis C; Keevil S; Sherwood R; Vivian G; Logan R; Summers J
    JMIR Res Protoc; 2016 Feb; 5(1):e13. PubMed ID: 26832436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validating biomarkers of treatable mechanisms in irritable bowel syndrome.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Neurogastroenterol Motil; 2014 Dec; 26(12):1677-85. PubMed ID: 25244349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.
    Camilleri M; Nadeau A; Tremaine WJ; Lamsam J; Burton D; Odunsi S; Sweetser S; Singh R
    Neurogastroenterol Motil; 2009 Jul; 21(7):734-e43. PubMed ID: 19368662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    Liu T; Ma M; Li K; Tan W; Yu H; Wang L
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):451-458. PubMed ID: 36867517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment.
    Barkun AN; Love J; Gould M; Pluta H; Steinhart H
    Can J Gastroenterol; 2013 Nov; 27(11):653-9. PubMed ID: 24199211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.
    Camilleri M; Shin A; Busciglio I; Carlson P; Acosta A; Bharucha AE; Burton D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(5):G508-16. PubMed ID: 25012842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile Acid diarrhea: prevalence, pathogenesis, and therapy.
    Camilleri M
    Gut Liver; 2015 May; 9(3):332-9. PubMed ID: 25918262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in understanding of bile acid diarrhea.
    Camilleri M
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):49-61. PubMed ID: 24410472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.